Abiopharma

New Form 424B3 - Aprea Therapeutics, Inc. <b>Filed:</b> 2026-03-19 <b>AccNo:</b> 0001104659-26-032181 <b>Size:</b> 231 KB

New Form ARS - RB GLOBAL INC. <b>Filed:</b> 2026-03-19 <b>AccNo:</b> 0001140361-26-010436 <b>Size:</b> 7 MB

New Form 13F-HR/A - BARCLAYS PLC <b>Filed:</b> 2026-03-19 <b>AccNo:</b> 0000312069-26-000081 <b>Size:</b> 3 MB

New Form S-4/A - Terra Property Trust, Inc. <b>Filed:</b> 2026-03-19 <b>AccNo:</b> 0001104659-26-032176 <b>Size:</b> 2 MB

Verrica Pharmaceuticals Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Verrica Pharmaceuticals Inc. – VRCA

New Form 424B3 - KAZIA THERAPEUTICS LTD <b>Filed:</b> 2026-03-19 <b>AccNo:</b> 0001193125-26-116194 <b>Size:</b> 342 KB

New Form 3 - STURM RUGER & CO INC <b>Filed:</b> 2026-03-19 <b>AccNo:</b> 0000095029-26-000032 <b>Size:</b> 2 KB

The company’s liability balance as of 31.12.25, by maturity dates

New Form 144/A - Aura Minerals Inc. <b>Filed:</b> 2026-03-19 <b>AccNo:</b> 0001958244-26-000167 <b>Size:</b> 5 KB

VGTel, Inc. Releases Follow-Up EEG Study Results, Establishing Baseline for Consciousness Research Integrated with UAP and Astronomy Initiatives

New Form DFAN14A - lululemon athletica inc. <b>Filed:</b> 2026-03-19 <b>AccNo:</b> 0001193125-26-116187 <b>Size:</b> 229 KB

New Form 424B3 - KAZIA THERAPEUTICS LTD <b>Filed:</b> 2026-03-19 <b>AccNo:</b> 0001193125-26-116185 <b>Size:</b> 342 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-03-19 <b>AccNo:</b> 0001213900-26-031946 <b>Size:</b> 347 KB

New Form 8-K/A - Cactus, Inc. <b>Filed:</b> 2026-03-19 <b>AccNo:</b> 0001628280-26-019875 <b>Size:</b> 3 MB <br />Item 9.01: Financial Statements and Exhibits

Periodic and annual report for 2025